BioCentury
ARTICLE | Company News

IsoTis OrthoBiologics sales and marketing update

July 26, 2004 7:00 AM UTC

ISON launched in the U.S. its OsSatura tri-calcium phosphate (TCP), a synthetic bone graft substitution. OsSatura TCP has faster resorption time than the existing OsSatura bi-calcium phosphate (BCP). ...